These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2187389)

  • 21. Patient selection is important in studying the impact of large-volume paracentesis on intravascular volume.
    Runyon BA
    Am J Gastroenterol; 1997 Mar; 92(3):371-3. PubMed ID: 9068453
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. At bat with paracentesis: home runs or singles?
    Simon D
    Am J Gastroenterol; 1991 Jan; 86(1):110. PubMed ID: 1986537
    [No Abstract]   [Full Text] [Related]  

  • 24. Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesis.
    Solbach P; Höner Zu Siederdissen C; Taubert R; Ziegert S; Port K; Schneider A; Hueper K; Manns MP; Wedemeyer H; Jaeckel E
    Eur J Gastroenterol Hepatol; 2017 May; 29(5):539-546. PubMed ID: 28350743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Refractory ascites?].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1990; 84(24):1239. PubMed ID: 2091395
    [No Abstract]   [Full Text] [Related]  

  • 26. [New therapeutic paradigm and concepts for patients with cirrhotic refractory ascites].
    Wang SZ; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):249-253. PubMed ID: 28494541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary function changes after large volume paracentesis.
    Berkowitz KA; Butensky MS; Smith RL
    Am J Gastroenterol; 1993 Jun; 88(6):905-7. PubMed ID: 8503387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites.
    Umgelter A; Reindl W; Franzen M; Lenhardt C; Huber W; Schmid RM
    Intensive Care Med; 2009 Jan; 35(1):152-6. PubMed ID: 18802688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Paracentesis associated to dextran-70 in the treatment of ascites in patients with chronic liver diseases: a randomized therapeutic study].
    Cotrim HP; Garrido V; Paraná R; Santana G; Dultra D; Pinto M; Lyra L
    Arq Gastroenterol; 1994; 31(4):125-9. PubMed ID: 7575171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diuretic-resistant ascites in cirrhosis. Mechanism and treatment.
    Arroyo V
    Acta Gastroenterol Belg; 1990; 53(2):249-55. PubMed ID: 2267904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ascites: medical therapy and paracentesis.
    Fevery J; Van Roey G; Van Steenbergen W
    Acta Gastroenterol Belg; 1996; 59(3):198-201. PubMed ID: 9015931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ascites. Current aspects of diagnosis and therapy].
    Schölmerich J; Volk BA; Köttgen E; Hasler C; Wilms H; Billmann P; Gerok W
    Dtsch Med Wochenschr; 1985 Mar; 110(13):512-8. PubMed ID: 2579785
    [No Abstract]   [Full Text] [Related]  

  • 33. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.
    Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W
    Crit Care; 2008; 12(1):R4. PubMed ID: 18197961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rational diuretic therapy in patients with liver cirrhosis].
    Vogt B; Reichen J
    Ther Umsch; 2000 Jun; 57(6):355-60. PubMed ID: 10894019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P; Arroyo V; Rodés J
    Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of ascites. A review.
    Watanabe A
    J Med; 1997; 28(1-2):21-30. PubMed ID: 9249607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ascites: pathophysiology, clinical aspects and therapeutic effectiveness].
    Frick E; Hollerbach S; Schölmerich J
    Krankenpfl J; 1992 Dec; 30(12):576-84. PubMed ID: 1293374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.